FFPE Tissue Samples Market Trend Analysis And Forecasts to 2027
The global FFPE Tissue Samples market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 2.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 4.1% during the prediction period 2021 to 2027.
The FFPE is a form of preparation and preservation for biopsy specimens, which helps in diagnostic/drug development, experimental research, and examination. A tissue sample is first fixed in formalin, also known as formaldehyde, to preserve vital structures and the proteins within the tissue. Subsequently, the tissue is embedded in a paraffin wax block; this helps for examination under a microscope. The global FFPE tissue samples market is expected to be driven by the expansion of the pharmaceutical sector during the forecast period.
North America held a major share of the global FFPE tissue samples market in 2020, due to high demand for FFPE tissue samples in the region. Additionally, technological advancements drive the demand for FFPE tissue samples, which is expected to augment the market in the region.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the FFPE Tissue Samples market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global FFPE Tissue Samples market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
FFPE Tissue Samples market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Market Opportunities:
In terms of application, the global FFPE tissue samples market has been classified into genomic study & analysis and proteomic study & analysis. The proteomic study & analysis segment dominated the global FFPE tissue samples market in 2020, and the trend is projected to continue during the forecast period. The genomic study & analysis segment has been split into whole genome sequencing & amplification, next generation sequencing, and DNA Extraction. The proteomic study & analysis segment has been segregated into protein extraction and clinical proteomics.
North America to Dominate Global Market; Asia Pacific to Offer Significant Opportunities
In terms of region, the global FFPE tissue samples market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to account for a leading share of the global FFPE tissue samples market during the forecast period. The FFPE tissue samples market in Asia Pacific is projected to expand at a rapid pace in the near future. India and China are likely to be lucrative markets for FFPE tissue samples during the forecast period.
| Report Highlights | Details |
| Market Size | US$ 2.1 Billion by 2027 |
| Growth Rate | CAGR of 4.1% From 2021 to 2027 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2027 |
| Segments Covered | Application,Tissue Sample Type,End User,Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | AMSBIO, BioChain Institute, Inc., Cureline, Discovery Life Sciences, Geneticist, Inc., Lab-Ally, Merck KGaA, OriGene Technologies, Inc., PrecisionMed, Inc., Pressure BioSciences, Inc., ProteoGenex, REPROCELL, Inc., and TriStar Technology Group LLC. These companies engage in the development of FFPE tissue samples in order to expand product offerings and customer base. |
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the FFPE Tissue Samples Market include: AMSBIO, BioChain Institute, Inc., Cureline, Discovery Life Sciences, Geneticist, Inc., Lab-Ally, Merck KGaA, OriGene Technologies, Inc., PrecisionMed, Inc., Pressure BioSciences, Inc., ProteoGenex, REPROCELL, Inc., and TriStar Technology Group LLC. These companies engage in the development of FFPE tissue samples in order to expand product offerings and customer base.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global FFPE Tissue Samples Market: Segmentation
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the FFPE Tissue Samples market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the FFPE Tissue Samples market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the FFPE Tissue Samples markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in FFPE Tissue Samples market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global FFPE Tissue Samples Market, By Application
7.1. FFPE Tissue Samples Market, by Application, 2021-2027
7.1.1. Genomic Study & Analysis
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Whole Genome Sequencing & Amplification
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Next Generation Sequencing
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. DNA Extraction
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Proteomic Study & Analysis
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Protein Extraction
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Clinical Proteomics
7.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global FFPE Tissue Samples Market, By Tissue Sample Type
8.1. FFPE Tissue Samples Market, by Tissue Sample Type, 2021-2027
8.1.1. FFPE Normal Tissue Samples
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. FFPE Diseased Tissue Samples
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global FFPE Tissue Samples Market, By End User
9.1. FFPE Tissue Samples Market, By End User, 2021-2027
9.1.1. Research & Scientific Laboratories
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Diagnostic Laboratories
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Specialized Clinics
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global FFPE Tissue Samples Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Application (2016-2027)
10.1.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.1.3. Market Revenue and Forecast, By End User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.1.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.1.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Application (2016-2027)
10.2.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.2.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.2.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.2.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.2.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.2.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Application (2016-2027)
10.3.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.3.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.3.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.3.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.3.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.3.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Application (2016-2027)
10.4.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.4.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.4.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.4.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.4.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Application (2016-2027)
10.5.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.5.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Tissue Sample Type (2016-2027)
10.5.5.3. Market Revenue and Forecast, By End User (2016-2027)
Chapter 11. Company Profiles
11.1. AMSBIO
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. BioChain Institute, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Cureline
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Discovery Life Sciences
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Discovery Life Sciences
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Lab-Ally
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Merck KGaA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Merck KGaA
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Merck KGaA
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers